Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Mesenchymal Stem Cell Transplantation for Diabetic Peripheral Neuropathy
ChiCTR-OIN-17010524Phase 2Recruiting
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Mar 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord mesenchymal stem cells in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Blood glucose level, HbA1c level and 2 more. Started Mar 2016; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-OIN-17010524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17010524.